Literature DB >> 21828246

Androgen receptor polyglutamine repeat length affects receptor activity and C2C12 cell development.

Ryan L Sheppard1, Espen E Spangenburg, Eva R Chin, Stephen M Roth.   

Abstract

Testosterone (T) has an anabolic effect on skeletal muscle and is believed to exert its local effects via the androgen receptor (AR). The AR harbors a polymorphic stretch of glutamine repeats demonstrated to inversely affect receptor transcriptional activity in prostate and kidney cells. The effects of AR glutamine repeat length on skeletal muscle are unknown. In this study we examined the effect of AR CAG repeat length on AR function in C2C12 cells. AR expression vectors harboring 14, 24, and 33 CAG repeats were used to assess AR transcriptional activity. C2C12 cell proliferation, differentiation, gene expression, myotube formation, and myonuclear fusion index were assessed. Transcriptional activity increased with increasing repeat length and in response to testosterone (AR14 = 3.91 ± 0.26, AR24 = 25.21 ± 1.72, AR33 = 36.08 ± 3.22 relative light units; P < 0.001). Ligand activation was increased for AR33 (2.10 ± 0.04) compared with AR14 (1.54 ± 0.09) and AR24 (1.57 ± 0.05, P < 0.001). AR mRNA expression was elevated in each stably transfected line. AR33 cell proliferation (20,512.3 ± 1,024.0) was decreased vs. AR14 (27,604.17 ± 1,425.3; P < 0.001) after 72 h. Decreased CK activity in AR14 cells (54.9 ± 2.9 units/μg protein) in comparison to AR33 (70.8 ± 8.1) (P < 0.05) was noted. The myonuclear fusion index was lower for AR14 (15.21 ± 3.24%) and AR33 (9.97 ± 3.14%) in comparison to WT (35.07 ± 5.60%, P < 0.001). AR14 and AR33 cells also displayed atypical myotube morphology. RT-PCR revealed genotype differences in myostatin and myogenin expression. We conclude that AR polyglutamine repeat length is directly associated with transcriptional activity and alters the growth and development of C2C12 cells. This polymorphism may contribute to the heritability of muscle mass in humans.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21828246      PMCID: PMC3217329          DOI: 10.1152/physiolgenomics.00049.2011

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  43 in total

1.  The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription.

Authors:  P Alen; F Claessens; G Verhoeven; W Rombauts; B Peeters
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men.

Authors:  K Krithivas; S M Yurgalevitch; B A Mohr; C J Wilcox; S J Batter; M Brown; C Longcope; J B McKinlay; P W Kantoff
Journal:  J Endocrinol       Date:  1999-07       Impact factor: 4.286

3.  Selective activation of the probasin androgen-responsive region by steroid hormones.

Authors:  S Kasper; P S Rennie; N Bruchovsky; L Lin; H Cheng; R Snoek; K Dahlman-Wright; J A Gustafsson; R P Shiu; P C Sheppard; R J Matusik
Journal:  J Mol Endocrinol       Date:  1999-06       Impact factor: 5.098

4.  Cyclin D1 binding to the androgen receptor (AR) NH2-terminal domain inhibits activation function 2 association and reveals dual roles for AR corepression.

Authors:  C J Burd; C E Petre; H Moghadam; E M Wilson; K E Knudsen
Journal:  Mol Endocrinol       Date:  2004-11-11

5.  Recruitment of the androgen receptor via serum response factor facilitates expression of a myogenic gene.

Authors:  Spiros Vlahopoulos; Warren E Zimmer; Guido Jenster; Narasimhaswamy S Belaguli; Steven P Balk; Albert O Brinkmann; Rainer B Lanz; Vassilis C Zoumpourlis; Robert J Schwartz
Journal:  J Biol Chem       Date:  2004-12-28       Impact factor: 5.157

6.  The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia.

Authors:  E Giovannucci; E A Platz; M J Stampfer; A Chan; K Krithivas; I Kawachi; W C Willett; P W Kantoff
Journal:  Urology       Date:  1999-01       Impact factor: 2.649

7.  Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility.

Authors:  T G Tut; F J Ghadessy; M A Trifiro; L Pinsky; E L Yong
Journal:  J Clin Endocrinol Metab       Date:  1997-11       Impact factor: 5.958

8.  Androgen receptor CAG repeat polymorphism is associated with fat-free mass in men.

Authors:  Sean Walsh; Joseph M Zmuda; Jane A Cauley; Patrick R Shea; E Jeffrey Metter; Ben F Hurley; Robert E Ferrell; Stephen M Roth
Journal:  J Appl Physiol (1985)       Date:  2004-09-17

9.  The CAG repeat within the androgen receptor gene and its relationship to prostate cancer.

Authors:  E Giovannucci; M J Stampfer; K Krithivas; M Brown; D Dahl; A Brufsky; J Talcott; C H Hennekens; P W Kantoff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

10.  Reduced differentiation potential of primary MyoD-/- myogenic cells derived from adult skeletal muscle.

Authors:  L A Sabourin; A Girgis-Gabardo; P Seale; A Asakura; M A Rudnicki
Journal:  J Cell Biol       Date:  1999-02-22       Impact factor: 10.539

View more
  8 in total

Review 1.  Genetic aspects of skeletal muscle strength and mass with relevance to sarcopenia.

Authors:  Stephen M Roth
Journal:  Bonekey Rep       Date:  2012-04-04

Review 2.  In Vitro and In Vivo Modeling of Spinal and Bulbar Muscular Atrophy.

Authors:  Maria Pennuto; Manuela Basso
Journal:  J Mol Neurosci       Date:  2015-11-27       Impact factor: 3.444

Review 3.  Genetic factors associated with exercise performance in atmospheric hypoxia.

Authors:  Philip J Hennis; Alasdair F O'Doherty; Denny Z H Levett; Michael P W Grocott; Hugh M Montgomery
Journal:  Sports Med       Date:  2015-05       Impact factor: 11.136

4.  The polyglutamine-expanded androgen receptor has increased DNA binding and reduced transcriptional activity.

Authors:  Sergey Belikov; Laura C Bott; Kenneth H Fischbeck; Örjan Wrange
Journal:  Biochem Biophys Rep       Date:  2015-07-26

Review 5.  Molecular Mechanisms and Therapeutics for SBMA/Kennedy's Disease.

Authors:  Frederick J Arnold; Diane E Merry
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

6.  Spatial expression of IKK-alpha is associated with a differential mutational landscape and survival in primary colorectal cancer.

Authors:  Meera Patel; Kathryn A F Pennel; Jean A Quinn; Hannah Hood; David K Chang; Andrew V Biankin; Selma Rebus; Antonia K Roseweir; James H Park; Paul G Horgan; Donald C McMillan; Joanne Edwards
Journal:  Br J Cancer       Date:  2022-02-16       Impact factor: 9.075

7.  The association between glutamine repeats in the androgen receptor gene and personality traits in dromedary camel (Camelus dromedarius).

Authors:  Sherif Ramadan; Amira M Nowier; Yusuke Hori; Miho Inoue-Murayama
Journal:  PLoS One       Date:  2018-02-07       Impact factor: 3.240

8.  Androgen receptor genetic variant predicts COVID-19 disease severity: a prospective longitudinal study of hospitalized COVID-19 male patients.

Authors:  J McCoy; C G Wambier; S Herrera; S Vaño-Galván; F Gioia; B Comeche; R Ron; S Serrano-Villar; R M Iwasiow; M A Tayeb; F A Cadegiani; N A Mesinkovska; J Shapiro; R Sinclair; A Goren
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-10-21       Impact factor: 9.228

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.